Methodology quality was inadequate for observational studies investigating drug safety of Chinese patent medicine using real-world data: A cross-sectional survey

Jiayue Xu; Wenkai Wu; Jundi Jia; Liang Du; Wen Wang; Xin Sun

doi:10.1111/jebm.12648

Journal of Evidence-Based Medicine ›› 2024, Vol. 17 ›› Issue (3) :483 -485. DOI: 10.1111/jebm.12648

LETTER

Methodology quality was inadequate for observational studies investigating drug safety of Chinese patent medicine using real-world data: A cross-sectional survey

Jiayue Xu ¹^,²^,³
, Wenkai Wu ¹^,²^,³^,⁴
, Jundi Jia ⁵^,⁶
, Liang Du ¹^,⁷
, Wen Wang ¹^,²^,³^,^†
, Xin Sun ¹^,²^,³^,⁴^,^†

Author information +

History +

PDF

Cite this article

Download citation ▾

Jiayue Xu, Wenkai Wu, Jundi Jia, Liang Du, Wen Wang, Xin Sun. Methodology quality was inadequate for observational studies investigating drug safety of Chinese patent medicine using real-world data: A cross-sectional survey. Journal of Evidence-Based Medicine, 2024, 17(3): 483-485 DOI:10.1111/jebm.12648